Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Rimmer, Joanne ^a   Fokkens, Wytske ^b   Chong, Lee Yee ^c   Hopkins, Claire ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UK COCHRANE CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; ANTIINFECTIVE AGENT;

CHRONIC RHINOSINUSITIS; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPIC ENDONASAL SURGERY; ENDOSCOPIC SINUS SURGERY; EPISTAXIS; EVIDENCE BASED MEDICINE; HUMAN; NOSE OBSTRUCTION; NOSE POLYP; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; ADULT; AGED; CHRONIC DISEASE; COMPLICATION; ENDOSCOPY; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; NASAL OBSTRUCTION; NASAL POLYPS; RHINITIS; SINUSITIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; ENDOSCOPY; EPISTAXIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL OBSTRUCTION; NASAL POLYPS; RHINITIS; SINUSITIS; STEROIDS;

EID: 84925226182     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD006991.pub2     Document Type: Review

References (60)

1. Alobid I, Benitez P, Bernal-Sprekelsen M, Roca J, Alonso J, Picado C, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 2005;60(4):452-8.
2. Lildholdt T, Fogstrup J, Gammelgaard N, Kortholm B, Ulsoe C. Surgical versus medical treatment of nasal polyps. Acta Otolaryngologica 1988;105(1):140-3.
3. Lildholdt T, Rundcrantz H, Bende M, Larsen K. Glucocorticoid treatment for nasal polyps. Archives of Otolaryngology, Head and Neck Surgery 1997;123(6):595-600.
4. Lildholdt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clinical Otolaryngology and Allied Sciences 1995;20(1):26-30. [PUBMED: 7788929]
5. Ragab S, Scadding GK, Lund VJ, Saleh H. Treatment of chronic rhinosinusitis and its effects on asthma. European Respiratory Journal 2006;28(1):68-74.
6. Ragab SM, Lund VJ, Saleh HA, Scadding G. Nasal nitric oxide in objective evaluation of chronic rhinosinusitis therapy. Allergy 2006;61(6):717-24.
7. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004;114(5):923-30.
8. Ragab SM, Lund VJ, Scadding G, Saleh HA, Khalifa MA. Impact of chronic rhinosinusitis therapy on quality of life: a prospective randomized controlled trial. Rhinology 2010;48(3):305-11.
9. Fokkens WJ. FES: FESS Effectiveness Study: a multi-centre randomised controlled trial studying the effectiveness of functional endoscopic sinus surgery (FESS) in adult patients with chronic rhinosinusitis/nasal polyps unresponsive to medical therapy. http://www.controlled-trials.com.
10. Rohail A, Malik MF, Awan AA. Comparison of conservative versus surgical treatment of ethmoidal nasal polyps. Pakistan Journal of Medical and Health Sciences 2010;4(3):184-7.
11. Sagit M, Erdamar H, Saka C, Yalcin S, Akin I. Effect of antioxidants on the clinical outcome of patients with nasal polyposis. Journal of Laryngology & Otology 2011;125:811-5.
12. Adams PF, Hendershot GE, Marano MA, Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital and Health Statistics. Series 10, Data from the National Health Survey 1999;10(200):1-203.
13. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. American Journal of Rhinology 2000;14(5):279-90.
14. Bachert C, Gevaert P, Holappels G, Johansson SGO, Van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. Journal of Allergy and Clinical Immunology 2001;107:607-14.
15. Bateman ND, Fahy C, Woolford T. Nasal polyps: still more questions than answers. Journal of Laryngology and Otology 2003;117(1):1-9.
16. CalenoffE, McMahan JT, Herzon GD. Bacterial allergy in nasal polyposis. Archives of Otolaryngology - Head and Neck Surgery 1993;119:830-6.
17. Caplin I, Haynes JT, Spahn J. Are nasal polyps an allergic phenomenon?. Annals of Allergy 1971;29:631-4.
18. Cervin A, Wallwork B. Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis. Current Allergy & Asthma Reports 2014;14(3):416.
19. Chin D, Harvey RJ. Nasal polyposis: an inflammatory condition requiring effective anti-inflammatory treatment. Current Opinion in Otolaryngology Head & Neck Surgery 2013;21(1):23-30.
20. Cleland EJ, Bassioni A, Boase S, Dowd S, Vreugde S, Wormald PJ. The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes. International Forum of Allergy and Rhinology 2014;4(4):259-65.
21. Clement PA, Gordts F. Consensus report on acoustic rhinometry and rhinomanometry. Rhinology 2005;43(3):169-79.
22. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinology 2012;23:1-298.
23. Glicklich R, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngology - Head and Neck Surgery 1995;113:104-9.
24. Greisner WA, Settipane GA. Hereditary factor for nasal polyps. Allergy and Asthma Proceedings 1996;17:283-6.
25. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
26. Hopkins C, Browne J, Slack R, Lund V, Brown P, van der Meulen J. Complications of sinonasal surgery. Laryngoscope 2006;116(8):1494-9.
27. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clinical Otolaryngology 2009;34(5):447-54.
28. Jamal A, Maran AGD. Atopy and nasal polyposis. Journal of Laryngology and Otology 1987;101:355-8.
29. Johansson L, Akerlund A, Holmberg K, Melén I, Bende M. Prevalence of nasal polyps in adults: the Skovde population based study. Annals of Otology, Rhinology, and Laryngology 2003;112(7):625-9.
30. Jones NS, Strobl A, Holland I. A study of CT findings in 100 patients with rhinosinusitis and 100 controls. Clinical Otolaryngology and Allied Sciences 1997;22:47-51.
31. Kalish L, Snidvongs K, Sivasubramaniam R, Cope D, Harvey RJ. Topical steroids for nasal polyps. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD006549.pub2]
32. Kennedy DW. Prognostic factors, outcomes and staging in ethmoids sinus surgery. Laryngoscope 1992;102:S1-18.
33. Lange B, Holst R, Thilsing T, Baelum J, Kjeldsen A. Quality of life and associated factors in persons with chronic rhinosinusitis in the general population. Clinical Otolaryngology 2013 Oct 16 [Epub ahead of print]. [DOI: 10.1111/coa.12189]
34. Larsen P, Tos M. Nasal polyps: epithelium and goblet cell density. Laryngoscope 1989;99(12):1274-80.
35. Larsen P, Tos M. Origin of nasal polyps: an endoscopic autopsy study. Laryngoscope 2004;114(4):710-9.
36. Lildholdt T. Surgical versus medical treatment of nasal polyps. Rhinology 1989;27(S8):31-3.
37. Lund VJ, Kennedy DW. Quantification for staging sinusitis. Annals of Otology, Rhinology & Laryngology Supplement 1995;167:17-21.
38. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngology - Head and Neck Surgery 1997;117:S35-S40.
39. Martinez-Devesa P, Patiar S. Oral steroids for nasal polyps. Cochrane Database of Systematic Reviews 2011, Issue 7. [DOI: 10.1002/14651858.CD005232.pub3]
40. Min YG, Jung HW, Kim HS, Park SK, Yoo KY. Prevalence and risk factors of chronic sinusitis in Korea: results of a nationwide survey. European Archives of Oto-rhino-laryngology 1996;253(7):435-9.
41. Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1, -DQA1, and -DQB1 genotypes in patients with nasal polyposis. Laryngoscope 2000;110(3 Pt 1):422-5.
42. Parnes S. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps. American Journal of Respiratory Medicine 2002;1(6):403-8.
43. Pawliczak R, Lewandowska-Polak A, Kowalski ML. Pathogenesis of nasal polyps: an update. Current Allergy and Asthma Reports 2005;5(6):463-71.
44. Piccirillo JF, Edwards D, Haiduk A, Yonan C, Thawley SE. Psychometric and Clinimetric Validity of the 31-Item Rhinosinusitis Outcome Measure (RSOM-31). American Journal of Rhinology 1995;9(6):297-306.
45. Piccirillo JF, Merritt MG Jr, Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngology - Head and Neck Surgery 2002;126(1):41-7.
46. Ponikau JU, Sherris DA, Kern EB. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clinic Proceedings 1999;74:877-84.
47. Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB, et al. Quality of life in nasal polyposis. Journal of Allergy and Clinical Immunology 1999;104(1):79-84.
48. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
49. Rugina M, Serrano E, Klossek JM, Crampette L, Stoll D, Bebear JP, et al. Epidemiological and clinical aspects of nasal polyps in France: the ORLI group experience. Rhinology 2002;40(2):75-9.
50. Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Annals of Internal Medicine 1968;68(5):975-83.
51. Sharma R, Lakhani R, Rimmer J, Hopkins C. Surgical interventions for chronic rhinosinusitis with nasal polyps. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD006990.pub2]
52. Slavin RG. Nasal polyps and sinusitis. JAMA 1997;278(22):1849-54.
53. Stammberger H. Functional Endoscopic Sinus Surgery. The Messerklinger Technique. Toronto: BC Decker, 1991.
54. Stoop AE, Van der Heijden HA, Biewenga J. Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study. Journal of Allergy and Clinical Immunology 1993;91(2):616-22.
55. Thulesius HL, Cervin A, Jessen M. The importance of side difference in nasal obstruction and rhinomanometry: a retrospective correlation of symptoms and rhinomanometry in 1000 patients. Clinical Otolaryngology 2012;37:17-22.
56. van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology 1994;32(1):5-9.
57. van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, Claeys C, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. Journal of Allergy and Clinical Immunology 2004;114(4):981-3.
58. Vento SI, Ertama LO, Hytonen ML, WolffCH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Annals of Allergy, Asthma and Immunology 2000;85(3):209-14.
59. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. American Journal of Rhinology 2000;14(3):143-8.
60. Zhang N, Gevaert P, van Zele T, Perez-Novo C, Patou J, Holtappels G, et al. An update on the impact of staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 2005;43(3):162-8.